NEW YORK (Reuters) Oct 31 - Allergan Inc on Wednesday said U.S. regulators approved its combination glaucoma drug Combigan. The company said Combigan eye drops would combine "two strong agents in one bottle" -- brimonidine and timolol -- that work through different mechanisms to control intraocular pressure
NEW YORK (Reuters) Oct 31 - Allergan Inc on Wednesday said U.S. regulators approved its combination glaucoma drug Combigan. The company said Combigan eye drops would combine "two strong agents in one bottle" -- brimonidine and timolol -- that work through different mechanisms to control intraocular pressure
FDA Approves Allergan Combo Eye Drop for Glaucoma